Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000446 · ClinicalTrials.gov registry record · Phase 2
Drug Treatment for Alcoholics With Post-Traumatic Stress Disorder
A Phase 2 study, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- Completed
- Registry status
- Phase 2
- Development phase
NCT00000446: Completed Phase 2 study, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
NCT00000446 is a Phase 2 study that has completed, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000446, a Phase 2 study, has completed, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
This study will investigate the use of sertraline (Zoloft) to decrease alcohol consumption and crime-related post-traumatic stress disorder in those individuals with both disorders. This will be a 12-week, placebo-controlled, double-blind outpatient trial. All subjects will receive cognitive behavioral therapy in addition to a placebo or sertraline. Comprehensive evaluation will be done at study entry; treatment termination; and 6, 9, and 12 months after study entry.
Interventions
- DRUG sertraline (Zoloft)
Trial Details
| Field | Value |
|---|---|
| Est. Completion | 2000-12 |
| Phase | Phase 2 |
What the finished NCT00000446 record still lists
NCT00000446 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which sertraline (Zoloft) is the first listed.
NCT00000446 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000446 about?
NCT00000446 is a clinical study titled "Drug Treatment for Alcoholics With Post-Traumatic Stress Disorder". This study will investigate the use of sertraline (Zoloft) to decrease alcohol consumption and crime-related post-traumatic stress disorder in those individuals with both disorders. This will be a 12-week, placebo-controlled, double-blind outpatient trial. All subjects will receive cognitive behavi...
What is the current status of trial NCT00000446?
This trial is currently completed. It is a Phase 2 study. Estimated completion is 2000-12.
What interventions are being tested in trial NCT00000446?
The interventions under investigation include: sertraline (Zoloft) (DRUG).
Who is sponsoring clinical trial NCT00000446?
This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.